# Taroh Kinoshita

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/taroh-kinoshita/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,959 |
| Field | Complement system in diseases |
| h-index | 89 |
| i10-index | 262 |
| Last Known Institution | Osaka International Cancer Institute |
| OpenAlex ID | https://openalex.org/A5072623856 |
| ORCID iD | 0000-0001-7166-7257 |
| Works | 437 |

## Researcher papers

Showing 12 of 13.

- [Symbol Nomenclature for Graphical Representations of Glycans](https://scholariq.org/papers/symbol-nomenclature-for-graphical-representations-of-glycans/)
- [Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria](https://scholariq.org/papers/deficiency-of-the-gpi-anchor-caused-by-a-somatic-mutation-of-the-pig-a-gene-in/)
- [Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle](https://scholariq.org/papers/direct-recognition-of-the-mycobacterial-glycolipid-trehalose-dimycolate-by-c/)
- [Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.](https://scholariq.org/papers/inhibition-of-complement-activation-on-the-surface-of-cells-after-incorporation/)
- [The Cloning of PIG-A, a Component in the Early Step of GPI-Anchor Biosynthesis](https://scholariq.org/papers/the-cloning-of-pig-a-a-component-in-the-early-step-of-gpi-anchor-biosynthesis/)
- [Updates to the Symbol Nomenclature for Glycans guidelines](https://scholariq.org/papers/updates-to-the-symbol-nomenclature-for-glycans-guidelines/)
- [Paroxysmal nocturnal haemoglobinuria](https://scholariq.org/papers/paroxysmal-nocturnal-haemoglobinuria/)
- [Genetic Variants in C5 and Poor Response to Eculizumab](https://scholariq.org/papers/genetic-variants-in-c5-and-poor-response-to-eculizumab/)
- [Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.](https://scholariq.org/papers/distribution-of-decay-accelerating-factor-in-the-peripheral-blood-of-normal/)
- [beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.](https://scholariq.org/papers/beta-2-microglobulin-modified-with-advanced-glycation-end-products-is-a-major/)
- [Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial](https://scholariq.org/papers/safety-and-efficacy-of-the-terminal-complement-inhibitor-eculizumab-in-japanese/)
- [Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial](https://scholariq.org/papers/long-term-efficacy-and-safety-of-eculizumab-in-japanese-patients-with-pnh-aegis/)

## Researcher topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Trypanosoma species research and implications](https://scholariq.org/topics/trypanosoma-species-research-and-implications/)
- [Lysosomal Storage Disorders Research](https://scholariq.org/topics/lysosomal-storage-disorders-research/)
- [Cellular transport and secretion](https://scholariq.org/topics/cellular-transport-and-secretion/)
- [Blood groups and transfusion](https://scholariq.org/topics/blood-groups-and-transfusion/)

## Researcher university

- [Osaka International Cancer Institute](https://scholariq.org/institutions/osaka-international-cancer-institute-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.